
Eric Blount
Examiner (ID: 14763, Phone: (571)272-2973 , Office: P/2684 )
| Most Active Art Unit | 2684 |
| Art Unit(s) | 2684, 2612, 2636, 2685 |
| Total Applications | 1590 |
| Issued Applications | 1210 |
| Pending Applications | 89 |
| Abandoned Applications | 303 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18860120
[patent_doc_number] => 20230414554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOUNDS FOR TREATING HEPATOCELLULAR CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 18/016295
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016295
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016295 | COMPOUNDS FOR TREATING HEPATOCELLULAR CARCINOMA | Jul 13, 2021 | Pending |
Array
(
[id] => 19097719
[patent_doc_number] => 20240116947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/014775
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014775
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014775 | PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS | Jul 13, 2021 | Abandoned |
Array
(
[id] => 17356735
[patent_doc_number] => 20220017531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => FLUORESCENT DYES
[patent_app_type] => utility
[patent_app_number] => 17/374514
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374514 | Fluorescent dyes | Jul 12, 2021 | Issued |
Array
(
[id] => 17355335
[patent_doc_number] => 20220016131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS FOR IMPROVED TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/371750
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371750 | Methods for improved treatment of cancer | Jul 8, 2021 | Issued |
Array
(
[id] => 18649315
[patent_doc_number] => 20230295103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => AURONE DERIVATIVES AND USES THEREOF FOR CONTROLLING BACTERIA AND/OR FUNGI
[patent_app_type] => utility
[patent_app_number] => 18/014762
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014762
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014762 | AURONE DERIVATIVES AND USES THEREOF FOR CONTROLLING BACTERIA AND/OR FUNGI | Jul 7, 2021 | Abandoned |
Array
(
[id] => 18753923
[patent_doc_number] => 20230357268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => PREPARATION AND APPLICATION OF TRICYCLIC PYRIMIDINONE COMPOUND AND ITS COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/004922
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004922
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004922 | PREPARATION AND APPLICATION OF TRICYCLIC PYRIMIDINONE COMPOUND AND ITS COMPOSITION | Jul 5, 2021 | Pending |
Array
(
[id] => 17369895
[patent_doc_number] => 20220024947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Purification of Rapamycin Derivatives Using Temperature Induced Phase Separation
[patent_app_type] => utility
[patent_app_number] => 17/360973
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360973 | Purification of rapamycin derivatives using temperature induced phase separation | Jun 27, 2021 | Issued |
Array
(
[id] => 18497317
[patent_doc_number] => 20230219934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => 2,3-DISUBSTITUTED PYRIDO[3,4-B]PYRAZINE-CONTAINING COMPOUNDS AS KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/009311
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009311 | 2,3-DISUBSTITUTED PYRIDO[3,4-B]PYRAZINE-CONTAINING COMPOUNDS AS KINASE INHIBITORS | Jun 23, 2021 | Pending |
Array
(
[id] => 18666221
[patent_doc_number] => 11773098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Solid forms of a toll-like receptor modulator
[patent_app_type] => utility
[patent_app_number] => 17/353462
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 32309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353462 | Solid forms of a toll-like receptor modulator | Jun 20, 2021 | Issued |
Array
(
[id] => 18444487
[patent_doc_number] => 11680045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => NLRX1 ligands
[patent_app_type] => utility
[patent_app_number] => 17/350032
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 65
[patent_no_of_words] => 23115
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350032 | NLRX1 ligands | Jun 16, 2021 | Issued |
Array
(
[id] => 20525322
[patent_doc_number] => 12543738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => 3-(pyridazin-4-yl)-5,6-dihydro-4H-1,2,4-oxadiazine derivatives as fungicides for crop protection
[patent_app_type] => utility
[patent_app_number] => 18/010736
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32929
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010736
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010736 | 3-(pyridazin-4-yl)-5,6-dihydro-4H-1,2,4-oxadiazine derivatives as fungicides for crop protection | Jun 15, 2021 | Issued |
Array
(
[id] => 17314409
[patent_doc_number] => 20210403457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => 2-OXOIMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/347639
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347639
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347639 | 2-oxoimidazolidine-4-carboxamides as NA | Jun 14, 2021 | Issued |
Array
(
[id] => 18738045
[patent_doc_number] => 20230346954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => N-1 BRANCHED IMIDAZOQUINOLINES, CONJUGATES THEREOF, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/002122
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002122
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002122 | N-1 BRANCHED IMIDAZOQUINOLINES, CONJUGATES THEREOF, AND METHODS | Jun 9, 2021 | Pending |
Array
(
[id] => 17343592
[patent_doc_number] => 20220009923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => DIHYDROPYRIDO[2,3-D]PYRIMIDINONE COMPOUNDS AS CDK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/344474
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344474 | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors | Jun 9, 2021 | Issued |
Array
(
[id] => 17385557
[patent_doc_number] => 20220033409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/343341
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343341 | BRM targeting compounds and associated methods of use | Jun 8, 2021 | Issued |
Array
(
[id] => 18666220
[patent_doc_number] => 11773097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Polymorphs of sepiapterin and salts thereof
[patent_app_type] => utility
[patent_app_number] => 17/342910
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 17857
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342910 | Polymorphs of sepiapterin and salts thereof | Jun 8, 2021 | Issued |
Array
(
[id] => 18628109
[patent_doc_number] => 20230286934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => Use of Multi-Kinase Inhibitors to Treat RNA Virus Infections
[patent_app_type] => utility
[patent_app_number] => 18/008282
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008282
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008282 | Use of Multi-Kinase Inhibitors to Treat RNA Virus Infections | Jun 7, 2021 | Abandoned |
Array
(
[id] => 18145997
[patent_doc_number] => 20230019853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/341877
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17341877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/341877 | Melanocortin 4 receptor antagonists and uses thereof | Jun 7, 2021 | Issued |
Array
(
[id] => 18524263
[patent_doc_number] => 20230234920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => Azirine Containing Compounds as Anti-Angiogenesis Agents and a Process for the Preparation Thereof
[patent_app_type] => utility
[patent_app_number] => 18/007960
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007960 | Azirine Containing Compounds as Anti-Angiogenesis Agents and a Process for the Preparation Thereof | Jun 3, 2021 | Pending |
Array
(
[id] => 18597173
[patent_doc_number] => 20230271965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => BICYCLIC HETEROARENES AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/007797
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007797
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007797 | BICYCLIC HETEROARENES AND METHODS OF THEIR USE | Jun 2, 2021 | Pending |